Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS BSE: 524412

₹69.28

(3.48%)

Mon, 30 Mar 2026, 04:39 am

MTF 5xInvest in Aarey Drugs & Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap1.95B

PE Ratio57.39

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Aarey Drugs & Pharmaceuticals EV/EBITDA Ratio

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	19.03	17.96	14.59	68.24	39.87	17.19	21.38	36.95	33.55	20.40	10.33	5.37	8.33	15.21	15.93	24.24	23.67
Price to book ratio	1.76	1.58	0.53	0.58	0.78	0.53	0.66	1.30	3.74	1.57	0.78	0.34	0.55	0.85	0.51	0.94	0.69
Price to sales ratio	0.54	0.31	0.18	0.15	0.15	0.09	0.11	0.19	0.46	0.36	0.19	0.10	0.16	0.20	0.14	0.29	0.20
Price to cash flow ratio	488.29	0	0	0	11.21	0	13.22	93.24	433.76	0	0	0	18.73	42.35	0	0	106.48
Enterprise value	158.58M	190.23M	144.41M	224.16M	304.98M	229.58M	341M	607.51M	1.93B	1.26B	833.68M	484.86M	716.2M	1.14B	966.81M	1.42B	1.27B
Enterprise value to EBITDA ratio	11.60	14.50	9.80	13.89	14.72	16.88	24.55	58.14	19.98	15.79	10.54	14.93	14.95	8.26	8.77	14.92	14.96
Debt to equity ratio	0.18	0.50	0.15	0.14	0.15	0.17	0.31	0.40	0.21	0.04	0.19	0.19	0.18	0.12	0.32	0.24	0.25
Return on equity %	0	9.21	5.08	1.04	1.99	3.09	3.11	3.58	12.75	9.46	7.84	6.48	6.81	6.17	3.26	3.74	2.97

Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio

The Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Aarey Drugs & Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Aarey Drugs & Pharmaceuticals Ltd (NSE: AAREYDRUGS, BSE: 524412) is currently trading at ₹69.28, with a market capitalization of ₹1.95B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Current Value

The current Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio stands at 14.96.

The latest Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

2024: 14.96
2023: 14.92
2022: 8.77
2021: 8.26
2020: 14.95

The recent rise in Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.

What Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Aarey Drugs & Pharmaceuticals Ltd.

Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Aarey Drugs & Pharmaceuticals Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800